Efficacy and Safety of Roxadustat in Patients with Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials including 6,518 Patients

Figure 4

(a) Forest plot of mean change from baseline in Hb level in DD study in patient with a C-reactive protein level above the upper limit of the normal range. (b) Funnel chart of mean change from baseline in Hb level in DD study in patient with a C-reactive protein level above the upper limit of the normal range.

(a)

(b)